High early mortality after percutaneous liver biopsy in metastatic cancer: national analysis.
Dominic Stephen KingBenjamin CouplandJemma MyttonJohn SpeakmanAnna LockNikhil SanyalLouisa NelmsSophie RaynerVeronica NantonAmandeep DosanjhPrashant PatelNigel TrudgillPublished in: BMJ supportive & palliative care (2024)
Mortality rates following liver biopsy for metastatic cancer are notably higher among patients undergoing emergency inpatient procedures. Clinicians should carefully weigh the risks and benefits of biopsy in elderly, comorbid or poor performance status patients. Multidisciplinary approaches involving palliative care may aid in decision-making for these patients.
Keyphrases
- palliative care
- end stage renal disease
- patients undergoing
- newly diagnosed
- small cell lung cancer
- ultrasound guided
- squamous cell carcinoma
- decision making
- papillary thyroid
- emergency department
- healthcare
- mental health
- public health
- patient reported outcomes
- type diabetes
- quality improvement
- squamous cell
- cardiovascular disease
- coronary artery disease
- minimally invasive
- human health